Growth Metrics

Organogenesis Holdings (ORGO) Net Income towards Common Stockholders: 2016-2024

Historic Net Income towards Common Stockholders for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$937,000.

  • Organogenesis Holdings' Net Income towards Common Stockholders rose 17.79% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year decrease of 81.48%. This contributed to the annual value of -$937,000 for FY2024, which is 118.95% down from last year.
  • Per Organogenesis Holdings' latest filing, its Net Income towards Common Stockholders stood at -$937,000 for FY2024, which was down 118.95% from $4.9 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Net Income towards Common Stockholders registered a high of $94.9 million during FY2021, and its lowest value of -$937,000 during FY2024.
  • In the last 3 years, Organogenesis Holdings' Net Income towards Common Stockholders had a median value of $4.9 million in 2023 and averaged $6.5 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Net Income towards Common Stockholders soared by 450.67% in 2021, and later tumbled by 118.95% in 2024.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Net Income towards Common Stockholders stood at $17.2 million in 2020, then surged by 450.67% to $94.9 million in 2021, then tumbled by 83.63% to $15.5 million in 2022, then plummeted by 68.16% to $4.9 million in 2023, then slumped by 118.95% to -$937,000 in 2024.